Operating Lease, Right-of-Use Asset of Kura Oncology, Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kura Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Kura Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $7,539,000, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Kura Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,539,000 +$1,439,000 +24% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $7,864,000 +$1,464,000 +23% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $8,139,000 +$1,441,000 +22% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $5,803,000 -$1,190,000 -17% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $6,100,000 -$1,181,000 -16% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $6,400,000 +$3,467,000 +118% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $6,698,000 +$3,307,000 +98% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $6,993,000 +$3,151,000 +82% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $7,281,000 +$2,997,000 +70% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $2,933,000 -$1,786,000 -38% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $3,391,000 -$1,758,000 -34% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $3,842,000 -$1,731,000 -31% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $4,284,000 -$1,705,000 -28% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $4,719,000 -$724,000 -13% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $5,149,000 -$800,000 -13% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $5,573,000 -$761,000 -12% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $5,989,000 -$722,000 -11% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $5,443,000 -$1,665,000 -23% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $5,949,000 +$3,749,000 +170% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $6,334,000 +$6,100,000 +2607% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $6,711,000 +$6,354,000 +1780% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $7,108,000 +$6,631,000 +1390% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $2,200,000 +$1,612,000 +274% 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 $234,000 -$366,000 -61% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $357,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $477,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $588,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $600,000 01 Jan 2019 10-K 25 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.